Le Lézard
Classified in: Health
Subject: ATY

Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AMLX


NEW YORK, Feb. 23, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") (NASDAQ: AMLX) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amylyx investors who were adversely affected by alleged securities fraud between November 11, 2022 and November 8, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/amylyx-lawsuit-submission-form?prid=67769&wire=4

AMLX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) defendants had overstated RELYVRIO's (a dual UPRBax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol, for the treatment of ALS in adults in the U.S.) commercial prospects; (ii) patients were discontinuing treatment with RELYVRIO after six months; (iii) the rate at which new patients were starting treatment with RELYVRIO was decreasing; (iv) accordingly, defendants had also overstated RELYVRIO's prescription rate; (v) defendants attempted to hide the foregoing negative trends from investors and the market by blocking analysts from viewing RELYVRIO's prescription data; and (vi) as a result, Defendants' public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you suffered a loss in Amylyx during the relevant time frame, you have until April 9, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


These press releases may also interest you

at 12:50
Data infrastructure and analytics company Kalderos, Inc., today announced that on Tuesday, April 16, it asked the Eighth Circuit for leave to file an amicus brief in support of Pharmaceutical Research and Manufacturers of America's (PhRMA's) petition...

at 12:20
Titan CEO and headline sponsor Wipfli LLP are pleased to announce Judith Nowlin, CEO of Nest Collaborative as a 2024 Colorado Titan 100. The Titan 100 program recognizes Colorado's Top 100 CEOs & C-level executives. They are the area's most...

at 12:18
Memorial Healthcare System and Solis Mammography, are pleased to announce the opening of the collaboration's first community-based breast screening centers in Weston, Plantation and Hialeah, Florida. The centers represent the commitment that both...

at 12:08
The Texas Center for Student Supports (TCSS) has chosen DialCare as an approved vendor for the Texas Stronger Connections Grant (SCG) under the category entitled "Software that Supports Students & Schools in Mental & Behavioral Health & Well-being."...

at 12:00
RELJA Innovations is excited to announce the recent launch of the RELJA Clamp. Designed by surgeons for surgeons, the RELJA Clamp is the first-of-its kind radiolucent, single-use bunion reduction clamp. Remarkably simple and intuitive by design, the...

at 11:41
Health-E Commerce®, parent brand to FSA Store® and HSA Store®, announced today that it will join benefits industry leaders as a sponsor of DataPath Connections April 29-May 1 in Sedona, AZ. The company will sponsor the conference welcome reception...



News published on and distributed by: